Homocysteine-thiolactone induces caspase-independent vascular endothelial cell death with apoptotic features

Apoptosis

Volumn 5, Issue 5, 2000, Pages 403-411

  Mercie P ^a   Garnier, O ^b   Lascoste, L ^b   Renard, M ^a   Closse, C ^a   Durrieu, F ^b   Marit, G ^a   Boisseau, R M ^a   Belloc, F ^a,b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

Apoptosis; Atherosclerosis; Cell culture; Endothelial function; Mitochondria

Indexed keywords

CASPASE; CATALASE; FUMONISIN B1; HOMOCYSTEINE; LEUPEPTIN; THIOLACTONE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL MEMBRANE POTENTIAL; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

APOPTOSIS; CARBOCYANINES; CASPASES; CELL DEATH; CELL LINE; CELL MEMBRANE; CULTURE MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FLUORESCENT DYES; HOMOCYSTEINE; HUMANS; MEMBRANE POTENTIALS; MITOCHONDRIA; PEPTIDE HYDROLASES; PHOSPHATIDYLSERINES; PROTEINS;

EID: 0034467166     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009652011466     Document Type: Article

References (42)

1. The role of apoptosis in vascular disease
2. Human ICE/CED-3 protease nomenclature
3. Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis
4. Commitment to apoptosis is associated with changes in mitochondrial biogenesis and activity in cell lines conditionally immortalized with simian virus 40
5. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis
6. Human neutrophils lose their surface Fc gamma RIII and acquire annexin V binding sites during apoptosis in vitro
7. Culture of human endothelial cells derived from umbilical veins
8. Caspase activation is an early event in anthracycline-induced apoptosis and allows detection of apoptotic cells before they are ingested by phagocytes
9. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
10. Ceramide-induced apoptosis occurs independently of caspases and is decreased by leupeptin
11. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine
12. Annexin V-affinity assay: A review of an apoptosis detection system based on phosphatidylserine exposure
13. Homocysteine-induced endothelial cell injury in vitro: A model for the study of vascular injury
14. The effect of the extracellular matrix on the detachment of human endothelial cells
15. Methods in laboratory investigation. Exclusion of trypan blue from microcarriers by endothelial cells: An in vitro barrier function test
16. Cell death by apoptosis and its protective role against disease
17. Apoptotic pathways: The roads to ruin
18. Caspase-independent programmed cell death with necrotic morphology
19. Retardation of chemical hypoxia-induced necrotic cell death by Bcl-2 and ICE inhibitors: Possible involvement of common mediators in apoptotic and necrotic signal transduction
20. Apoptosis and necrosis: Intracellular ATP level as a determinant for cell death modes
21. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl
22. Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis
23. Characterization of two distinct mechanisms for induction of apoptosis in human vascular endothelial cells
24. Atherogenic lipoproteins, oxidative stress, and cell death
25. Oxidized-LDL induce apoptosis in HUVEC but not in the endothelial EA. hy 926
26. Apoptosis induced by lack of hemodynamic forces is a general endothelial feature even occurring in immortalized cell lines
27. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis
28. Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis
29. The effect of homocysteine on DNA synthesis in cultured human vascular smooth muscle
30. Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor
31. The pathogenesis of atherosclerosis - A perspective for the 1990's
32. Hyperhomocysteinaemia and endothelial dysfunction in peripheral arterial disease
33. Factor V Leiden, mild hyperhomocyst(e)inemia and Buerger's disease
34. Measurement of plasma thiols after derivatization with monobromobimane
35. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen
36. Effect of thiol oxidation and thiol export from erythrocytes on determination of redox status of homocysteine and other thiols in plasma from healthy subjects and patients with cerebral infarction
37. Hyperhomocyst(e)inemia and atherothrombosis
38. Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence
39. Metabolism of homocysteine thiolactone in human cell cultures: Possible mechanism for pathological consequences of elevated homocysteine levels
40. Homocysteine thiolactone and protein homocysteinylation in human endothelial cells
41. Protein homocysteinylation: Possible mechanism underlying pathological consequences of elevated homocysteine levels
42. The redox status of aminothiols as a clue to homocysteine-induced vascular damage?